Canada: Promotion Of Drugs and Devices At International Conferences Held In Canada

Last Updated: February 4 2009
Article by Eileen McMahon and Laila Paszti

This article first appeared in Update, Issue 1, January/February 2009.

Reprinted with permission of the Food and Drug Law Institute (FDLI) ©2009.

As a neighbor, Canada is often selected as a venue for international conferences of U.S. drug and device manufacturers. Products and uses advertised at these Canadian conferences can be 1) approved in the United States but not in Canada, 2) approved in Canada but not the United States, or 3) approved in neither country. Pharmaceutical companies are increasingly seeking to understand Canadian laws regarding off-label promotion—that is, promoting these products for a use different from that approved by the regulatory authorities—to avoid running afoul of these authorities, whether they are acting on their own or working with the U.S. Department of Justice (DOJ).1

Impact of U.S. Off-label Prosecution

Off-label promotion of pharmaceutical products has resulted in stiff penalties imposed by the DOJ. Fines totaling several hundred million dollars as well as civil and criminal charges against pharmaceutical companies and their personnel are making pharmaceutical companies scrutinize their advertising practices and adopt a cautious approach to advertising—not only domestically but also at international conferences, including ones held in Canada.

With a spate of high-profile prosecutions, the DOJ has firmly entrenched itself in an area traditionally occupied by the U.S. Food and Drug Administration (FDA) alone—namely, the policing of pharmaceutical companies' promotional activities.2

Canadian Law

Given the enforcement activities of DOJ, it is hardly surprising that pharmaceutical companies are considering the effect of Canadian laws on their promotional practices at international conferences, particularly ones where sales representatives intend to promote unapproved drugs, unapproved devices or their uses. The Canadian Food and Drug Act,3 administered by Health Canada, defines the general parameters for allowable advertising of drugs and medical devices. Section 9.1 of the Act states that no person shall advertise any drug in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety. Section 20.1 has a similar prohibition regarding the advertising of medical devices. The Act also sets out more explicit rules for advertising certain products.

With respect to advertising new drugs, section C.08.002 of the regulations under the Act states that no person shall sell or advertise a new drug unless the manufacturer of the new drug has filed a new drug submission or an abbreviated new drug submission relating to the new drug and the Minister of Health has issued a notice of compliance (an approval) for the new drug. The Act defines the word "sell" to include an offer for sale, expose for sale, have in possession for sale and distribute—whether or not the distribution is made for consideration. "Advertising" is defined more broadly to include any representation by any means whatsoever for the purpose of promoting directly or indirectly the sale or disposal of any food, drug, cosmetic or device.

To clarify the definition of advertising under the Act, Health Canada has issued guidelines titled "The Distinction between Advertising and Other Activities."4 The guidelines attempt to clarify the distinction between advertising to promote the sale of a drug and activities that are not primarily intended to promote the sale of a drug. These non-promotional activities include education, scientific exchange, labeling and shareholder reports. The distinction is drawn by determining the primary purpose of the message through a variety of factors, including the context in which the message is disseminated, the primary and secondary audiences, the provider of the message, the sponsor of the message, the influence exerted by the manufacturer, the frequency and repetition of the message and the actual content of the message. Thus, although advertising of unapproved drugs, uses and devices is prohibited, information regarding these unapproved therapeutic products may be presented at international conferences provided this is done through a non-promotional activity. Displaying an unapproved drug or off-label use may constitute a non-promotional activity if the following four factors are present:

  1. First, the conference must clearly be an international event in that a significant proportion of the conference delegates must be from other jurisdictions.
  2. Second, the promotional material must emanate from the parent company of the manufacturer.
  3. Third, the material must be for use only within the confines of the conference.
  4. Fourth, the material is prominently identified as not being authorized for sale in Canada.

Although there is no corresponding guideline for medical devices, the guideline can be a helpful reference for manufacturers planning to advertise unapproved medical devices.

Failure to comply with the legislative requirements for drug or device advertising in Canada is a criminal offence, punishable by up to three years imprisonment and/or a fine of up to C$5,000. In addition, the Minister may penalize non-complying manufacturers by refusing licenses or creating regulatory difficulties. A new federal bill was recently introduced to allow the Minister to take stronger action.

There are also more general laws that apply to advertising. The federal Competition Act, which prohibits misrepresentation to the public, and various provincial consumer acts must be considered when promoting unapproved products.

In addition, various industry associations have adopted self-regulating measures. The Pharmaceutical Advertising Advisory Board (PAAB), an independent multidisciplinary body that reviews and approves drug advertising and promotional materials, administers the PAAB Code of Advertising Acceptance. In theory, compliance with the PAAB Code is voluntary although it is strongly encouraged by Health Canada. The PAAB has a complaint procedure that is usually instigated by competitors complaining about activities of other industry members. Similarly, MEDEC is an industry association comprising companies from the medical devices industry. MEDEC has a Code of Conduct that applies to the promotion of devices, and members are encouraged to practice ethical business activities and not to use any unlawful inducements to promote their products.

Useful Tips

Pharmaceutical companies intending to advertise unapproved products or uses at an international conference in Canada may find the following list of practical tips useful.

  • Advertising, Displaying and Promoting Products and Uses
  1. If a pharmaceutical company is advertising a product or use that is approved in Canada but not in all attendees' jurisdictions, including the United States, Health Canada's position is that the product or use can be advertised, displayed and promoted at the conference, and indeed within Canada, provided that the claims made are consistent with the Canadian product's approval. Health Canada is unlikely to penalize the promotion of products that are unapproved in foreign attendees' jurisdictions.5 In practice, at an international conference, some companies include in the promotional material a statement that the product may not be approved outside Canada. However, Health Canada does not require that such statements be included.
  2. If a product or use is unlicensed in Canada but licensed in the United States, a company must indicate on the marketing material or at the booths that the products or uses are "not authorized for use within Canada" as required by Health Canada guidelines.
  3. If a device is unapproved anywhere in the world, the product may be displayed within the confines of the conference provided that the product is prominently identified as not being authorized for sale in Canada. Health Canada has provided no guidance concerning the placement and appearance of a disclaimer that will satisfy the requirement that the materials "prominently identify" the product or use as not being authorized for sale in Canada. To meet the requirement, the disclaimer must be likely to come to the attention of the reader. Often, the disclaimer is positioned immediately below the unapproved claim, in the same font size as the unapproved claim.
  • Discussion with Customers
  1. Note that the content of discussions with customers will depend on whether the customer is from Canada or the United States. A sales representative who is speaking to a U.S. customer about a product or use approved only in the United States may discuss the product or use with the American customer, in compliance with U.S. laws regarding advertisement of the product.
  1. The sales representative may not discuss with a Canadian attendee a product or use that is not approved in Canada. If, however, the Canadian customer makes an unsolicited request for information about the off-label use, the sale representative would refer the Canadian customer to a scientific affairs representative for further discussion. That person would then be permitted to discuss the unapproved product or use in response to the unsolicited question.
  2. A log would be kept of all unsolicited requests for information documenting the specific request, the name of the individual requesting the information and the fact that the information is being provided in response to the request. Although a scientific affairs person may respond to an unsolicited question about information regarding an unapproved product or use, that person should not solicit conversation regarding an unapproved product or use because this would be considered promotion of an unapproved product or use.
  • Posters
  1. Posters that refer to a product or product use before it is authorized in Canada are permissible in the context of an international conference provided that the materials prominently identify the product or use as not being authorized for sale in Canada as set out in Health Canada's guidelines.
  • Reprints of Articles and Abstracts
  1. Reprints of articles or abstracts on unapproved products or uses should be distributed only in response to an unsolicited request for information. The reprints or abstracts should not be on display at the booth but should be concealed either under the table or behind the booth. Both a sales representative and scientific affairs person can distribute reprints or abstracts in response to unsolicited questions, but the sales representative should not engage the customer in any discussion and should instead steer the customer to scientific affairs.


Pharmaceutical and medical device companies advertising their products at international conferences held in Canada may wish to have regard to the above factors when preparing their advertising. Such an approach would be prudent, given the strong stance that regulators take against off-label promotion.


1 The DOJ enforces the criminal provisions of the Food, Drug and Cosmetic Act. Offenders may also be prosecuted under the Anti-Kickback statute and the False Claims Act.

2 The prosecution of Jazz Pharmaceutical Inc. illustrates the extent to which penalties, both civil and criminal, can be levied against guilty parties. As part of the settlement on July 13, 2007, Jazz paid $20 million dollars and admitted that its subsidiary Orphan Medical Inc. engaged in a scheme to expand the market for Xyrem by promoting off-label use to physicians. The indictment of the Swiss corporation Serono S.A. and its U.S. subsidiaries in December 2005, while less recent, serves as a warning regarding the size of the fines. The corporation paid $704 million to resolve criminal charges and civil liability for several illegal schemes to promote and sell its drug, Serostim, which was approved in 1996 to treat Auto-Immune Deficiency Syndrome (AIDS) wasting.

3 Food and Drug Act, R.S.C., 1985, c. F-27.

4 Health Canada, The Distinction Between Advertising and Other Activities (Oct. 4, 2005), available at pdf/advert-publicit/actv_promo_vs_info-eng.pdf.

5 The Act excludes from its jurisdiction drugs exported for sale that indicate that Health Canada would not have jurisdiction over drugs sold or offered for sale in any country other than Canada. International regulatory authorities of countries in which the drug or uses are not approved are unlikely to attempt to enforce their laws at international conferences outside their geographic boundaries. There is no evidence that DOJ officials are either asking Health Canada to attend the conference on their behalf to help with enforcement or actually attending the conference to assert jurisdiction within Canada. No notices of this type of enforcement appear on Health Canada's website.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.